beta
Trial Radar AI
Clinical Trial NCT07501741 for Femoral Neck Fractures is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Comparison of the Direct Anterior Approach (DAA) and the Direct Lateral Approach (DLA) in Patients Treated With Partial Hip Replacement for Femoral Neck Fracture Based on Postoperative Functional Status 100

Not yet recruiting
Clinical Trial NCT07501741 is an observational study for Femoral Neck Fractures and is currently not yet recruiting. Enrollment is planned to begin on May 1, 2026 and continue until the study accrues 100 participants. Led by Meir Medical Center, this study is expected to complete by May 1, 2028. The latest data from ClinicalTrials.gov was last updated on March 30, 2026.
Brief Summary

The goal of this clinical trial is to learn whether the surgical approach used for hemiarthroplasty can improve clinical and functional outcomes in adults with displaced femoral neck fractures.

The main questions it aims to answer are:

  • Does the direct anterior approach (DAA) result in superior postoperative functional recovery compared with the direct lateral approach (DLA)?
  • Are mortality, complications, hospit...
Show More
Official Title

Impact of Surgical Approach on Post-Fracture Function: A Prospective Hemiarthroplasty Study

Conditions
Femoral Neck Fractures
Other Study IDs
  • 0046-26-MMC
NCT ID Number
NCT07501741
Start Date (Actual)
2026-05-01
Last Update Posted
2026-03-30
Completion Date (Estimated)
2028-05
Enrollment (Estimated)
100
Study Type
Observational
Status
Not yet recruiting
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Harris Hip Score (HHS) - Postoperative Functional Outcome at 6 Weeks and 3 Months Following Hemiarthroplasty
Functional outcome will be assessed using the Harris Hip Score (HHS), a validated 100-point scale evaluating pain, function, deformity, and range of motion, collected at 6 weeks and 3 months postoperatively.
6 weeks and 3 months post-surgery
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Incidence of Treatment-Related Complications Following Hemiarthroplasty
Number of participants with one or more complications- Including intraoperative blood loss, blood transfusions, implant dislocation, implant failure, surgical site infection, and other adverse events.
During hospitalization and up to 3 months post-surgery
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All

Adults aged 18 years or older Patients undergoing hemiarthroplasty (partial hip replacement) during the study period at Meir Medical Center Ability to provide informed consent for participation in the study

Revision surgery performed during the index hospitalization Inability to complete postoperative follow-up Inability to provide informed consent (e.g., dementia or presence of a legal guardian) Pre-injury mobility status of bedbound or wheelchair-bound Polytrauma patients Prior fixation or arthroplasty of the contralateral hip within the previous year
Meir Medical Center logoMeir Medical Center28 active studies to explore
No contact data.